Angelisun (Chongqing) Pharmaceutical Co., Ltd.

Chongqing Angronxiang is a group company integrating drug research and development, production and sales. The company has subsidiaries: Chongqing Angronxiang Pharmaceutical Co., Ltd., Chongqing Angronxiang Pharmaceutical Technology Co., Ltd. and Chongqing Angronxiang Pharmaceutical. Industry Co., Ltd. Chongqing Anger Longxiang Pharmaceutical Technology Co., Ltd., as the group's R&D center, is located in Chongqing Erlang International Students Science and Technology Pioneer Park. It is a modern standard drug R&D experimental center with an area of ​​1,500 square meters. Currently, the main areas involved are anti-tumor and cardiovascular drugs, and it is committed to the discovery and research of new drugs (including synthesis technology, preparation technology, product quality research), technical services, technical consulting and drug registration. Chongqing Anger Longxiang Pharmaceutical Co., Ltd. is located in Changshou Industrial Park, a national heavy chemical base, covering an area of ​​more than 60 acres and a production workshop of more than 12,000 square meters, including more than 1,800 square meters of GMP purification area. It currently has hundreds of employees. The company's environmental protection treatment system meets the requirements of national standards. It has established 2 API production lines and 1 preparation production line. Currently, 1 preparation variety and 4 API varieties have obtained production approval, and more than 10 varieties are in the R&D application stage. The company is building a multi-functional solid preparation production line and will soon become a comprehensive enterprise with multiple API production lines and preparation production lines. Chongqing Anger Longxiang Pharmaceutical Co., Ltd. is a high-quality pharmaceutical marketing team. The company's marketing network has covered major hospitals in Sichuan and Chongqing and has offices in Chengdu. The annual sales amount is approximately 100 million yuan.